[PDF][PDF] 肿瘤心脏病学——一门超越心血管毒性管理的学科

洪翔婵, 谭文勇 - 肿瘤防治研究, 2018 - zlfzyj.com
patients with suspected cardiotoxicity in our … cancer patients with cardiac diseases. Such
approach however may not be associated with the expected clinical response or cardiovascular

基于文献计量学的国内外肿瘤心脏病学研究现状与热点分析

李孟娟, 刘莹, 张艳丽, 刘萌垚, 薛亚男, 苏丽萍… - 中国癌症 …, 2022 - china-oncology.com
… on cancer treatment and cardiovascular toxicity from … "heart failure", "breast cancer"
and "cardiotoxicity", while the most frequently used keywords in China were "cardiotoxicity", "cardiac

应用超声心动图评价阿霉素所致兔扩张型心肌病模型的实验研究

费洪文, 王新房, 谢明星… - 中国临床药理学与治疗 …, 2005 - manu41.magtech.com.cn
… , which is used in chemotherapy for the treatment of several cancers in humans .One well-…
gestive heart failure which was due to a proposed calcium overload and its direct cardiotoxicity

[PDF][PDF] 蒽环类药物所致心脏毒性的磁共振研究进展

田瑶天, 王翠艳 - 磁共振成像, 2022 - med-sci.cn
Cardiac magnetic resonance (CMR), as a noninvasive … role in the baseline evaluation and
follow-up of AIC due to its … for cardiotoxicity prediction in a cohort of breast cancer patients

[PDF][PDF] 曲妥珠单抗治疗1 8 5 例HER2 阳性乳腺癌患者的心脏安全性评价

孟文静, 张继博, 李淑芬, 佟仲生 - 肿瘤防治研究, 2018 - zlfzyj.com
… The treatment of trastuzumab on Chinese patients with HER2 positive breast cancer shows a
satisfactory cardiac … However, the potential cardiotoxicity of trastuzumab should be carefully …

[PDF][PDF] 血管紧张素转换酶抑制剂/血管紧张素受体拮抗剂和β 受体阻滞剂对乳腺癌患者曲妥珠单抗心脏毒性预防作用的meta 分析

陈灿, 李倩雯, 王春晖, 庞雨时, 李晓宇 - 药物不良反应杂志, 2022 - cadrj.com
cardiotoxicity in female breast cancer patients, who were treated with trastuzumab containing
regimens and without underlying cardiacrisk due to cardiotoxicity in breast cancer patients

[HTML][HTML] 真实世界中肺癌免疫检查点抑制剂治疗的安全性及有效性

许杨悦, 胡蒙, 武常玲, 孙重期 - 南京医科大学学报(自然科学版), 2023 - jnmu.njmu.edu.cn
Cancer immuno⁃ therapy with check point inhibitor can cause autoimmune adverse events
due … volved in immune checkpoint inhibitors cardiotoxicity and challenges to improve clinical …

免疫检查点抑制剂及其心血管不良反应研究进展

张志仁 - 药学进展, 2018 - pps.cpu.edu.cn
… Glucocorticoid and immunosuppressants are the mainstays of current treatment. Routine
monitoring of cardiovascular adverse effects is essential for patients receiving treatment with …

多发性骨髓瘤患者并发急性心力衰竭的危险因素分析及预测模型构建

张菊红, 冯春, 劳钰, 樊永旺, 王琰, 靳文 - 华南预防医学, 2024 - hnyfyx.cn
: 目的通过分析多发性骨髓瘤(multiple myeloma, MM) 患者并发急性心力衰竭(acute heart failure,
AHF) 的危险因素, 建立预测MM 并发AHF 风险的列线图预测模型. 方法本研究回顾性收集广东…

阿霉素诱导心肌病小鼠模型的构建

张庆领, 张云鹏, 周赞东, 张跃, 刘彤 - 中国癌症杂志, 2022 - china-oncology.com
… MMP inhibitors attenuate doxorubicin cardiotoxicity by … mediated cardiotoxicity through
regulation of cardiac circular … against anthracycline toxicity to cardiomyocytes due to its strong …